行情

ABEO

ABEO

Abeona
NASDAQ

实时行情|Nasdaq Last Sale

3.000
+0.240
+8.70%
盘后: 3.080 +0.08 +2.67% 19:03 12/06 EST
开盘
2.810
昨收
2.760
最高
3.040
最低
2.590
成交量
166.80万
成交额
--
52周最高
9.55
52周最低
1.460
市值
1.53亿
市盈率(TTM)
-1.8864
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ABEO 新闻

  • SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
  • ACCESSWIRE.1天前
  • SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline ABEO
  • GlobeNewswire.1天前
  • Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Bloom Energy Corporation (BE)
  • GlobeNewswire.2天前
  • Abeona Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
  • Newsfile.2天前

更多

所属板块

生物技术和医学研究
+0.66%
制药与医学研究
+0.49%

热门股票

名称
价格
涨跌幅

ABEO 简况

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB). It is also developing ABO-101 (AAV-NAGLU) for Sanfilippo syndrome type B (MPS IIIB), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), EB-201 for epidermolysis bullosa, ABO-301 (AAV-FANCC) for Fanconi anemia disorder and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy for rare blood diseases. The Company also has a plasma-based protein therapy pipeline, including alpha-1 protease inhibitor (SDF Alpha) for inherited COPD, using its proprietary Salt Diafiltration ethanol-free process.
展开

Webull提供Abeona Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。